AltruBio is a biotechnology company that specializes in the development of therapies for the treatment of immunological diseases. The company's focus is on the creation of novel monoclonal antibodies designed to target T-cell activation pathways that are implicated in autoimmune and inflammatory diseases. AltruBio's proprietary technology and innovative approach aim to provide effective and targeted treatment options for patients with unmet medical needs.